<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:PEN (USA) Also Trade In: Germany

Penumbra Inc $ 147.21 0.31 (0.21%)

Volume:
178,265
Avg Vol (1m):
556,356
Market Cap $:
5.12 Bil
Enterprise Value $:
4.98 Bil
P/E (TTM):
490.73
P/B:
11.73
Warning! GuruFocus has detected 2 Severe warning signs with PEN. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for PEN (Penumbra) from 2015 to Oct 21 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Penumbra stock (PEN) PE ratio as of Oct 21 2019 is 490.73. More Details

Penumbra PE Ratio (TTM) Chart

EMBED

Penumbra PE Ratio (TTM) Historical Data

Total 1061
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Penumbra PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-21377.5 2019-08-19367.8
2019-10-18377.5 2019-08-16372.3
2019-10-17376.7 2019-08-15372.4
2019-10-16374.9 2019-08-14380.8
2019-10-15376.6 2019-08-13389.7
2019-10-14371.1 2019-08-12381.7
2019-10-11374.2 2019-08-09378.4
2019-10-10365.9 2019-08-08383.5
2019-10-09364.9 2019-08-07377.0
2019-10-08353.3 2019-08-06424.7
2019-10-07368.2 2019-08-05404.7
2019-10-04374.5 2019-08-02415.7
2019-10-03356.9 2019-08-01430.3
2019-10-02347.5 2019-07-31429.7
2019-10-01345.7 2019-07-30460.2
2019-09-30344.9 2019-07-29464.0
2019-09-27338.5 2019-07-26462.5
2019-09-26346.4 2019-07-25465.7
2019-09-25358.9 2019-07-24470.3
2019-09-24359.7 2019-07-23454.5
2019-09-23369.3 2019-07-22439.0
2019-09-20379.2 2019-07-19451.6
2019-09-19379.0 2019-07-18453.5
2019-09-18384.8 2019-07-17446.3
2019-09-17388.8 2019-07-16435.1
2019-09-16388.3 2019-07-15442.9
2019-09-13382.1 2019-07-12435.1
2019-09-12382.4 2019-07-11442.3
2019-09-11375.5 2019-07-10436.0
2019-09-10360.0 2019-07-09425.6
2019-09-09349.2 2019-07-08421.9
2019-09-06338.0 2019-07-05417.1
2019-09-05343.6 2019-07-04409.5
2019-09-04359.7 2019-07-03409.5
2019-09-03375.8 2019-07-02419.1
2019-09-02373.2 2019-07-01411.5
2019-08-30373.2 2019-06-28410.3
2019-08-29372.2 2019-06-27533.4
2019-08-28366.3 2019-06-26539.9
2019-08-27362.2 2019-06-25556.6
2019-08-26365.6 2019-06-24548.6
2019-08-23358.3 2019-06-21549.4
2019-08-22371.6 2019-06-20550.7
2019-08-21370.6 2019-06-19554.7
2019-08-20370.3 2019-06-18558.0

Penumbra PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Medical Devices » Medical Devices NAICS : 339999 NAICS : 3841
Traded in other countries 0P8.Germany PEN.USA
Address One Penumbra Place, 1351 Harbor Bay Parkway, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for us by specialist physicians. The neurovascular product category contributes the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.